Literature DB >> 1694991

Drug binding and solubility in milk.

P E Macheras1, M A Koupparis, S G Antimisiaris.   

Abstract

The binding and solubility of nitrofurantoin, piroxicam, indomethacin, prednisolone, diazepam, dicumarol, and griseofulvin in milk were determined at 15, 25, and 37 degrees C in bovine milk samples with fat contents of 0.75 and 3.50%. Drug binding to milk components was independent of drug concentration over the drug concentration studied, and the fat content of milk strongly affected binding values of most of the listed drugs. Further, drug binding increased with decreasing temperatures for most of the drugs examined. The solubility of all drugs is greatly enhanced in milk compared to their aqueous solubility (pH 6.5 phosphate buffer). The high solubility cannot be accounted for solely on the basis of drug binding to milk components. An attempt is made to correlate the binding and solubility data with physicochemical properties of the drugs (logP, pKa, aqueous solubility). The potential significance of these findings is discussed with regard to preparation and in vivo delivery of drugs from drug-milk formulations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694991     DOI: 10.1023/a:1015881103340

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  A high-speed liquid chromatographic analysis of indomethacin in plasma.

Authors:  G G Skellern; E G Salole
Journal:  J Chromatogr       Date:  1975-11-26

2.  Effect of temperature and fat content on the solubility of hydrochlorothiazide and chlorothiazide in milk.

Authors:  P E Macheras; M A Koupparis; S G Antimisiaris
Journal:  J Pharm Sci       Date:  1989-11       Impact factor: 3.534

3.  Studies on drug-milk freeze-dried formulations. I: Bioavailability of sulfamethizole and dicumarol formulations.

Authors:  P E Macheras; C I Reppas
Journal:  J Pharm Sci       Date:  1986-07       Impact factor: 3.534

4.  Effect of temperature and fat content on the binding of hydrochlorothiazide and chlorothiazide to milk.

Authors:  P E Macheras; M A Koupparis; S G Antimisiaris
Journal:  J Pharm Sci       Date:  1988-04       Impact factor: 3.534

5.  Determination of cortisol in human plasma by reversed-phase high-performance liquid chromatography.

Authors:  N R Scott; P F Dixon
Journal:  J Chromatogr       Date:  1979-09-11

6.  Non-isotopic spectrophotometric determination of the unbound fraction of drugs in serum.

Authors:  C F Lim; K N Wynne; J M Barned; D J Topliss; J R Stockigt
Journal:  J Pharm Pharmacol       Date:  1986-11       Impact factor: 3.765

7.  Simultaneous determination of diazepam and its metabolies N-desmethyldiazepam, oxydiazepam and oxazepam in plasma and urine of man and dog by means of high-performance liquid chromatography.

Authors:  T B Vree; A M Baars; Y A Hekster; E van der Kleijn; W J O'Reilly
Journal:  J Chromatogr       Date:  1979-04-11

8.  Thermodynamics of distribution of p-substituted phenols between aqueous solution and organic solvents and phospholipid vesicles.

Authors:  N H Anderson; S S Davis; M James; I Kojima
Journal:  J Pharm Sci       Date:  1983-04       Impact factor: 3.534

9.  Simple, rapid, and micro high-pressure liquid chromatographic determination of plasma griseofulvin levels.

Authors:  R L Nation; G W Peng; V Smith; W L Chiou
Journal:  J Pharm Sci       Date:  1978-06       Impact factor: 3.534

10.  Correlation of serum binding of penicillins with partition coefficients.

Authors:  A E Bird; A C Marshall
Journal:  Biochem Pharmacol       Date:  1967-12       Impact factor: 5.858

View more
  15 in total

1.  Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data.

Authors:  E Nicolaides; E Galia; C Efthymiopoulos; J B Dressman; C Reppas
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

2.  Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.

Authors:  Eleni Rinaki; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

3.  Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS.

Authors:  Georgia Charkoftaki; Aristides Dokoumetzidis; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2012-07-04       Impact factor: 4.200

4.  Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update.

Authors:  Ekarat Jantratid; Niels Janssen; Christos Reppas; Jennifer B Dressman
Journal:  Pharm Res       Date:  2008-04-11       Impact factor: 4.200

5.  Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System.

Authors:  Nadia Bou-Chacra; Katherine Jasmine Curo Melo; Ivan Andrés Cordova Morales; Erika S Stippler; Filippos Kesisoglou; Mehran Yazdanian; Raimar Löbenberg
Journal:  AAPS J       Date:  2017-05-17       Impact factor: 4.009

Review 6.  Lipids in the Stomach - Implications for the Evaluation of Food Effects on Oral Drug Absorption.

Authors:  Mirko Koziolek; Frédéric Carrière; Christopher J H Porter
Journal:  Pharm Res       Date:  2018-02-08       Impact factor: 4.200

7.  An in vitro technique for the rapid determination of drug entry into breast milk.

Authors:  L J Notarianni; D Belk; S A Aird; P N Bennett
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

8.  Excretion of indomethacin in breast milk.

Authors:  T H Lebedevs; R E Wojnar-Horton; P Yapp; M J Roberts; L J Dusci; L P Hackett; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

9.  Studies on the excretion of diazepam and nordazepam into milk for the prediction of milk-to-plasma drug concentration ratios.

Authors:  T Stebler; T W Guentert
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

10.  Distribution of indomethacin in human milk and estimation of its milk to plasma ratio in vitro.

Authors:  L Beaulac-Baillargeon; G Allard
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.